Trial Outcomes & Findings for Symptom Management for YA Cancer Survivors (NCT NCT04035447)

NCT ID: NCT04035447

Last Updated: 2025-06-29

Results Overview

Intervention satisfaction will be assessed using the Satisfaction witth Therapy and Therapist Scale-Revised, a 13-item measure with the first 12-items on a five-point scale ranging from 1 "strongly disagree" to 5 "strongly agree." The 13th item (Global Improvement) asks, "How much did the intervention help with your symptoms?" with 5 answer choices ranging from "made things a lot better" (1) to "made things a lot worse" (5). Each of the subscales (Satisfaction With Therapy and Satisfaction With Therapist) range from 6 to 30, with higher scores indicating greater overall satisfaction. A total score is calculated as the sum of the first twelve items, with possible scores from 12 to 60, with higher scores indicating greater overall satisfaction.

• Recruitment status: COMPLETED
• Study phase: NA
• Target enrollment: 65 participants
• Primary outcome timeframe: Following completion of the intervention, up to 12 months
• Results posted on: 2025-06-29

Participant Flow

Participants were recruited from a comprehensive cancer center.

Of 65 enrolled patients, 4 patients were excluded prior to randomization: two lost to follow up, one subject withdrawal, and one PI withdrawal due to disease progression.

Unit of analysis: Cohorts

Participant milestones

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Treatment Period STARTED	31 3	30 3
Treatment Period COMPLETED	25 3	23 3
Treatment Period NOT COMPLETED	6 0	7 0
Waitlist Cross-over STARTED	27 3	0 0
Waitlist Cross-over COMPLETED	27 3	0 0
Waitlist Cross-over NOT COMPLETED	0 0	0 0

Reasons for withdrawal

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Treatment Period Lost to Follow-up	6	5
Treatment Period Physician Decision	0	2

Baseline Characteristics

Symptom Management for YA Cancer Survivors

Baseline characteristics by cohort

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=31 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=30 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.	Total n=61 Participants Total of all reporting groups
Age, Continuous	33 years n=5 Participants	34 years n=7 Participants	34 years n=5 Participants
Sex: Female, Male Female	22 Participants n=5 Participants	22 Participants n=7 Participants	44 Participants n=5 Participants
Sex: Female, Male Male	9 Participants n=5 Participants	8 Participants n=7 Participants	17 Participants n=5 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	2 Participants n=5 Participants	3 Participants n=7 Participants	5 Participants n=5 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	29 Participants n=5 Participants	27 Participants n=7 Participants	56 Participants n=5 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=5 Participants	1 Participants n=7 Participants	1 Participants n=5 Participants
Race (NIH/OMB) Asian	2 Participants n=5 Participants	1 Participants n=7 Participants	3 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	2 Participants n=5 Participants	5 Participants n=7 Participants	7 Participants n=5 Participants
Race (NIH/OMB) White	24 Participants n=5 Participants	20 Participants n=7 Participants	44 Participants n=5 Participants
Race (NIH/OMB) More than one race	3 Participants n=5 Participants	1 Participants n=7 Participants	4 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants	2 Participants n=7 Participants	2 Participants n=5 Participants
Region of Enrollment United States	31 Participants n=5 Participants	30 Participants n=7 Participants	61 Participants n=5 Participants

PRIMARY outcome

Timeframe: Following completion of the intervention, up to 12 months

Population: Participants who completed at least one intervention session.

Intervention satisfaction will be assessed using the Satisfaction witth Therapy and Therapist Scale-Revised, a 13-item measure with the first 12-items on a five-point scale ranging from 1 "strongly disagree" to 5 "strongly agree." The 13th item (Global Improvement) asks, "How much did the intervention help with your symptoms?" with 5 answer choices ranging from "made things a lot better" (1) to "made things a lot worse" (5). Each of the subscales (Satisfaction With Therapy and Satisfaction With Therapist) range from 6 to 30, with higher scores indicating greater overall satisfaction. A total score is calculated as the sum of the first twelve items, with possible scores from 12 to 60, with higher scores indicating greater overall satisfaction.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=28 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=24 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Intervention Satisfaction: Satisfaction With Therapy and Therapist Scale-Revised (STTS-R) Satisfaction With Therapy (ST)	26.71 scores on a scale Standard Deviation 3.52	27.33 scores on a scale Standard Deviation 3.14
Intervention Satisfaction: Satisfaction With Therapy and Therapist Scale-Revised (STTS-R) Global Improvement (Item 13)	1.75 scores on a scale Standard Deviation 0.52	1.58 scores on a scale Standard Deviation 0.65
Intervention Satisfaction: Satisfaction With Therapy and Therapist Scale-Revised (STTS-R) Satisfaction With Therapist (SWT)	28.86 scores on a scale Standard Deviation 1.86	27.75 scores on a scale Standard Deviation 3.27

PRIMARY outcome

Timeframe: Following completion of the intervention, up to 12 months

Population: Participants who completed at least one intervention session.

Intervention will be evaluated using 3 open-ended questions, including the following: "1) What was the most helpful part of the program?," "2) What was the least helpful part of the program?", and "3) What suggestions do you have for us to help improve the program?"

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=28 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=24 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Number of Participants Who Completed Open-Ended Questions About the Program	28 Participants	24 Participants

PRIMARY outcome

Timeframe: Following completion of the intervention, up to 12 months

Population: Any participant who had at least one intervention session was included for analysis.

Treatment feasibility will be assessed by measuring the session attendance rate for each participant.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=28 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=27 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Percentage of Sessions Attended by Each Participant	91.96 percentage of sessions Standard Deviation 23.87	94.27 percentage of sessions Standard Deviation 18.42

PRIMARY outcome

Timeframe: Following completion of the intervention, up to 12 months

Population: One participant in the waitlist control condition was excluded from analysis due to an incomplete response to the measure.

The Treatment Acceptability Questionnaire is a six-item scale assessing participants' views of an intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable") and averaged.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=28 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=23 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Treatment Acceptability Questionnaire	6.54 score on a scale Standard Deviation 0.41	6.36 score on a scale Standard Deviation 0.83

PRIMARY outcome

Timeframe: Following completion of the intervention, up to 12 months

Population: Any participant who had at least one intervention session was included for analysis.

Participants' use of intervention strategies will be assessed using a measure developed specific to components of the proposed intervention. Participants will be asked about how frequently treatment strategies discussed in session have been used outside of session since the previous session or last assessment depending on the timing of the questionnaire. A scale ranging from 0 "not at all" to 5 "every day" will be used.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=28 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=27 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Use of Intervention Strategies	2.35 score on a scale Standard Deviation 0.83	2.67 score on a scale Standard Deviation 1.24

PRIMARY outcome

Timeframe: Following completion of the intervention, up to 12 months

Population: Any participant who had at least one intervention session was included for analysis.

Participants' use of the mobile application will be assessed using a measure developed specific to components of the proposed mobile application. Participants will be asked about how frequently they have used components of the mobile application outside of session since the previous session or last assessment depending on the timing of the questionnaire. A scale ranging from 0 "not at all" to 5 "2 or more times a day" will be used.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=28 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=27 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Self-reported Use of the Mobile Application	0.79 score on a scale Standard Deviation 0.9	0.96 score on a scale Standard Deviation 1.37

SECONDARY outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment, pre-intervention (baseline for Intervention, 6 months for Waitlist Control) and post-intervention (3 months for Intervention, 9 months for Waitlist Control) reported

Population: Respondents were included if they provided a complete response to the measure. All participants received the intervention.

Depressive Symptoms will be assessed using the Patient Reported Outcomes Measurement Information System Depression Short Form-8a, an 8-item measure assessing symptoms of depression in the last week. Participants are asked to respond to items (e.g., "I felt sad," "I felt helpless") using a five-point scale ranging from 1 "never" to 5 "always." Items are summed and converted to standardized t-scores with a mean of 50 and standard deviation of 10. Higher T-scores indicate higher levels of depression. T-scores of 55 to 60 indicate mild levels of depression, 60 to 70 indicates moderate levels of depression, and greater than 70 indicate severe levels of depression.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=60 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=55 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Change in Depressive Symptoms: PROMIS Depression Short Form	50.3 T-score Standard Deviation 10.2	48.7 T-score Standard Deviation 9.6

SECONDARY outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment, pre-intervention (baseline for Intervention, 6 months for Waitlist Control) and post-intervention (3 months for Intervention, 9 months for Waitlist Control) reported

Population: Respondents were included if they provided a complete response to the measure. All participants received the intervention.

Symptoms of Anxiety will be assessed using the Patient Reported Outcomes Measurement Information System Anxiety Short Form-8a, an 8-item measure assessing symptoms of anxiety in the last week. Participants are asked to respond to items (e.g., "I felt nervous," "I felt tense") using a five-point scale ranging from 1 "never" to 5 "always". Total scores are then converted to T-scores. Items are summed and converted to standardized t-scores with a mean of 50 and standard deviation of 10. Higher T-scores indicate higher levels of anxiety. T-scores of 55 to 60 indicate mild levels of anxiety, 60 to 70 indicates moderate levels of anxiety, and greater than 70 indicate severe levels of anxiety.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=60 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=55 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Change in Anxiety: PROMIS Anxiety Short Form	53.1 T-score Standard Deviation 12	52.6 T-score Standard Deviation 12

SECONDARY outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment, pre-intervention (baseline for Intervention, 6 months for Waitlist Control) and post-intervention (3 months for Intervention, 9 months for Waitlist Control) reported

Population: Respondents were included if they provided a complete response to the measure. All participants received the intervention.

Symptom interference will be assessed using the Illness Intrusiveness Rating Scale (IIRS). The IIRS assesses the extent to which an illness and/ or its treatments interfere with 13 quality of life domains (e.g., health, diet, work, sex life, active recreation). Items are rated on a 7-point scale from 1 "not very much" to 7 "very much." The total score ranges from 7 to 91, where a higher score indicates greater interference.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=57 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=48 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Change in Symptom Interference: Illness Intrusiveness Rating Scale	36.4 score on a scale Standard Deviation 20	32.8 score on a scale Standard Deviation 17.4

SECONDARY outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment; pre-intervention (baseline for Intervention, 6 months for Waitlist Control) and post-intervention (3 months for Intervention, 9 months for Waitlist Control) reported

Population: Respondents were included if they provided a complete response to the measure. All participants received the intervention.

The Brief Pain Inventory is a 9-item, self-report measure assessing pain severity and interference from pain across important life domains (e.g., general activity, work, relations with others). Participants rate their pain on a scale from 0 "no pain" to 10 "pain as bad as you can imagine." Pain severity is calculated as the average of four items assessing participants' worst, least, current, and average (in the last week) pain on a scale from 0 "no pain" to 10 "worst pain." Pain interference is computed as the average of seven items, which ask about the interference of pain across different life domains (e.g., general activity, mood, relations with other people).

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=60 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=52 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Change in Pain: Brief Pain Inventory Pain Severity	2.1 score on a scale Standard Deviation 2	1.7 score on a scale Standard Deviation 1.9
Change in Pain: Brief Pain Inventory Pain Interference	2.2 score on a scale Standard Deviation 2.3	1.9 score on a scale Standard Deviation 2.3

SECONDARY outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment, pre-intervention (baseline for Intervention, 6 months for Waitlist Control) and post-intervention (3 months for Intervention, 9 months for Waitlist Control) reported

Population: All participants received the intervention.

Fatigue will be assessed using the Patient Reported Outcomes Measurement Information System Fatigue Scale, a 6-item self-report measure of fatigue. Participants are asked to think about the last week when responding to each item (e.g., "In the past 7 days, how run-down did you feel, on average?"). Items are summed and converted to standardized t-scores with a mean of 50 and standard deviation of 10. A higher score indicates greater fatigue. T-scores of 55 to 60 indicate mild levels of fatigue, 60 to 70 indicates moderate levels of fatigue, and greater than 70 indicate severe levels of fatigue.

Outcome measures

Measure	Behavioral Symptom Management for Young Adult Cancer Survivors n=60 Participants The intervention provides systematic training in cognitive and behavioral coping skills (e.g., activity-rest cycling, cognitive defusion, relaxation training) delivered over the course of 8 sessions (12 therapy hours). By employing these strategies, participants learn to adjust their behaviors and emotions as well as interact differently with their thoughts in the service of better managing symptoms.	Waitlist Control n=55 Participants Waitlist control participants will receive the intervention and receive systematic training in cognitive and behavioral coping skills approximately 6 months into their participation in the study.
Change in Fatigue: PROMIS Fatigue Short Form	54 T-score Standard Deviation 10.8	55.4 T-score Standard Deviation 9.3

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The International Physical Activity Questionnaire is a seven-item questionnaire that assesses the amount of time participants have spent doing physical activity (e.g., moderate physical activities, vigorous physical activities, walking) in the last seven

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The Stanford LCAT is a categorical item that assesses the type of physical activities participants do.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The FACIT assesses the spiritual wellbeing of participants with 12-item questionnaire on a scale from 0 = "not at all" to 4 = "very much."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The AAQ is a 7-item questionnaire to track psychological flexibility related to coping with cancer and cancer treatment. The scale ranges from 1 = "never true" to 7 "always true." Item is scored by adding all of the responses together.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The VQ is a 10-item self-report questionnaire with a scale 0 = "not true at all" to 6 "completely true."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Following completion of the intervention, up to 12 months

The 17-item Group Therapy Experiences Scale will be used to assess the level of cohesion among group members (e.g., development of positive relationships, comfort level with other group members). Items 1-16 are rated on a 5-point scale with 1 = "strongly agree" to 5 = "strongly disagree." Item 17 is an open-ended question, "was there something in the group today that helped or hindered you?"relationships, comfort level with other group members). Items are rated on a 4-point scale with 1= "strongly disagree" to 4= "strongly agree."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The PROMIS Social Isolation Scale is a 6-item measure is used to assess social isolation. Participants are asked to rate each item (e.g., "I felt left out," "I feel that people avoid talking to me") on a scale from 1= "never" to 5= "always."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The Self-Efficacy for Managing Chronic Disease Scale is a 6-item scale. Participants rate their confidence in keeping pain, fatigue, emotional distress, and other symptoms from interfering with things they want to do on a scale from 1 "not at all confident" to 10 "totally confident."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The PROMIS Self-Efficacy for Managing Chronic Conditions - Managing Symptoms - Short Form 4a is a 4-item scale. Participants rate their confidence in managing their symptoms during daily activities, with relationships with friends and family, in a public place, and working with their doctor to manage these symptoms on a scale from 1 = "I am not at all confident" to 5 "I am very confident."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The PROMIS Emotional Support Short Form is a 6-item measure used to assess emotional support. Participants are asked to rate each item ("I have someone who will listen to me when I need to talk," "I have someone to talk with when I have a bad day") on a scale from 1= "never" to 5= "always."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The PROMIS Instrumental Support Short Form is a 6-item measure used to assess instrumental support. Participants are asked to rate each item (e.g., "Do you have someone to take you to the doctor if you needed it?," "Do you have someone to prepare your meals if you are unable to do it yourself?") on a scale from 1= "never" to 5= "always."

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline and again 3, 6, 9, and 12 months following the baseline assessment

The PROMIS Informational Support Short Form is a 6-item measure used to assess informational support. Participants are asked to rate each item (e.g., "I have someone to turn to for suggestions about how to deal with a problem," "I have someone to give me information if I need it") on a scale from 1= "never" to 5= "always."

Outcome measures

Outcome data not reported

Adverse Events

Behavioral Symptom Management for Young Adult Cancer Survivors

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Waitlist Control - Intervention

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Waitlist Control - No Intervention

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Caroline Dorfman, PhD

Duke University School of Medicine

Phone: 919-416-3473

Email: caroline.dorfman@duke.edu

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place